Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
     L01A ALKYLATING AGENTS
     L01B ANTIMETABOLITES
     L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
     L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
     L01E PROTEIN KINASE INHIBITORS
     L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
     L01X OTHER ANTINEOPLASTIC AGENTS
       L01XA Platinum compounds [DG:DG01679]
       L01XB Methylhydrazines
       L01XD Sensitizers used in photodynamic/radiation therapy
       L01XF Retinoids for cancer treatment
       L01XG Proteasome inhibitors [DG:DG03134]
       L01XH Histone deacetylase (HDAC) inhibitors [DG:DG03133]
       L01XJ Hedgehog pathway inhibitors [DG:DG01566]
       L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors [DG:DG02942]
       L01XL Antineoplastic cell and gene therapy
       L01XX Other antineoplastic agents
         L01XX01 Amsacrine
         L01XX02 Asparaginase
         L01XX03 Altretamine
         L01XX05 Hydroxycarbamide
         L01XX07 Lonidamine
         L01XX08 Pentostatin
         L01XX10 Masoprocol
         L01XX11 Estramustine [DG:DG00724]
         L01XX16 Mitoguazone
         L01XX18 Tiazofurine
         L01XX23 Mitotane
         L01XX24 Pegaspargase
         L01XX27 Arsenic trioxide
         L01XX29 Denileukin diftitox
         L01XX33 Celecoxib
         L01XX35 Anagrelide [DG:DG00727]
         L01XX36 Oblimersen [DG:DG00728]
         L01XX40 Omacetaxine mepesuccinate
         L01XX41 Eribulin
         L01XX44 Aflibercept
         L01XX52 Venetoclax
         L01XX53 Vosaroxin
         L01XX57 Plitidepsin
         L01XX58 Epacadostat
         L01XX59 Enasidenib [DG:DG02837]
           D10901  Enasidenib (USAN/INN)
           D11044  Enasidenib mesylate (USAN) <US>
         L01XX62 Ivosidenib
         L01XX66 Selinexor
         L01XX67 Tagraxofusp
         L01XX69 Lurbinectedin
         L01XX72 Tazemetostat [DG:DG03020]
         L01XX73 Sotorasib
         L01XX74 Belzutifan
         L01XX75 Tebentafusp
         L01XX77 Adagrasib
         L01XX78 Navitoclax [DG:DG03204]
         L01XX79 Eflornithine [DG:DG00440]
         L01XX80 Imetelstat [DG:DG03283]
       L01XY Combinations of antineoplastic agents
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 16, 2024
According to WHO's ATC 2024

» Japanese version